Vanguard® crLyme

50 x 1 Dose

ZOETIS

Patterson Item #:

07-892-5877

Manufacturer Item #:

10012888

 
Good through December 31, 2018. Buy 175 Doses Get 25 Doses Free and 200 Syringes Buy 325 Doses Get 50 Doses Free 300 Syringes Buy 600 Doses Get 100 Doses Free 600 Syringes Buy 800 Doses Get 150 Doses Free 800 Syringes Buy 1,000 Doses Get 200 Doses Free 1,000 Syringes *Free Syringe SKUs: 078925994 or 078925993 *Mix and Match. *Free Vaccine must be equal to or less expensive SKU as long as it does not exceed the number of doses ordered of the more expensive SKU. *Syringes will be rounded up when billed doses are within 25 does of the next 100 doses. *Customer Exclusions: All customers enrolled on Contract, Bid price, and/or marketing program which offers discounts on CAD vaccines

Promotion Expires:

12/31/2018

 
Good through February 9, 2018. *Vets, customer exclusions apply* 1 brand 10-49 Cases, Get 4% Rebate 2 brands 10-49 Cases, Get 6% Rebate 3 brands 10-49 Cases, Get 8% Rebate 4 brands 10-49 Cases, Get 10% Rebate 5 brands 10-49 Cases, Get 12% Rebate 1 brand 50-120 Cases, Get 6% Rebate 2 brands 50-120 Cases, Get 8% Rebate 3 brands 50-120 Cases, Get 10% Rebate 4 brands 50-120 Cases, Get 12% Rebate 5 brands 50-120 Cases, Get 14% Rebate *Case Conversions: 10 cards of Revolution/Simparica 6 dose = 1 case 20 cards of Revolution/Simparica 3 dose = 1 case ProHeart 6 2 vials = 1 case 5 vials = 2 cases 10 vials = 4 cases Diroban (3) 5pk boxes = 1 case Vanguard 50x1ds tray = 1 case Vanguard 25x1ds tray = ½ case *Orders placed and invoiced January 8, 2018 through February 9, 2018 will receive a rebate check by March 30, 2018.

Promotion Expires:

02/09/2018

# Per Package:
50 x 1 Dose
Selling Unit of Measure:
Each
Doses Per Unit:
50 Doses
Biological Type:
Recombinant
Container Type:
Vial
Delivery Type:
Injection
Diseases Indicated For:
Lyme Disease

Description

Vanguard crLyme helps provide broad spectrum coverage against outer surface protein A (OspA), found in the tick, and contains antigens from multiple types of outer surface protein C (OspC), found in the tick and dog.

Indication: For vaccination of healthy dogs 8 weeks of age or older as an aid in prevention of clinical disease and subclinical arthritis associated with Borrelia burgdorferi. Key Benefits:
  • The first Lyme disease vaccine for dogs to contain a recombinant OspC protein
  • Demonstrated efficacy in helping prevent Lyme infection
  • Excellent performance in a field safety study
  • Thimerosal free
  • Covered by Companion Animal Immunization Support Guarantee (ISG)
Additional Information
DEA
Hazmat - Chargeable
Ice
List 1
MSDS
My eCustom Catalog
Hazmat - No Charge
Pedigree
Prescription
Promotion
This item is on your Formulary list.
New Arrivals